A vaccine directed against tumor blood vessels suppress tumor growth and metastasis
11/12/2014
In a new study published in the scientific journal Oncotarget researchers from Uppsala University show that a therapeutic vaccine directed against tumor vessels can reduce tumor burden and suppress...
Discovery may advance breast cancer treatment
11/12/2014
Researchers led by Dr. Debra Auguste, associate professor, biomedical engineering, in the Grove School of Engineering at The City College of New York, have identified a molecule that could lead to...
Medicare patients with poor prognosis cancers who received hospice care had significantly lower rates of hospitalization, intensive care unit (ICU) admissions and invasive procedures at the end...
Acute rejection after kidney transplantation occurs in about 15%-20% of patients despite immunosuppressive therapy.
US skin cancer costs rise from 2002 through 2011
11/11/2014
The costs associated with skin cancer increased five times as fast as treatments for other cancers between 2002 and 2011, according to a CDC study published online in the American Journal of...
New treatment for cervical cancer developed using anti-alcohol drug
11/11/2014
Researchers have found using an anti-alcoholism drug in a vaginal ring could reduce the side effects experienced by cervical cancer patients during treatment.
Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced positive interim data...
Researchers discover new target for blood cancer treatment
11/11/2014
Scientists at the University of York have identified a therapeutic target which could lead to the development of new treatments for specific blood cancers.
The efficacy of folfiri in a colorectal cancer subtype challenged by CNIO scientists
11/11/2014
The current classification system for colorectal cancer, which is based on genetic expression profiles, cannot be used to predict drug responses to FOLFIRI.
Proof of minor added benefit in one patient group / Hint or indication of lesser benefit in othersEribulin (trade name: Halaven) is approved for women with locally advanced or metastatic breast...